Page 1 of Clinical Trials for HDAC, 373 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Histone Deacetylases - Gastric Cancer (HDAC-GaCa-2008)
Last Updated: February 7, 2012
Condition(s): Metastatic Gastric Cancer
2
Not yet recruiting
Dietary Histone Deacetylase Inhibitors (HDAC)
Last Updated: March 1, 2012
Condition(s): HDAC Activity
3
Recruiting
Chemoprevention of Prostate Cancer, HDAC Inhibition and DNA Methylation
Last Updated: August 12, 2011
Condition(s): Prostate Cancer Prevention
4
Completed
Effect of Symbicort on HAT and HDAC in Sputum Macrophages of COPD
Last Updated: April 4, 2008
Condition(s): Chronic Obstructive Pulmonary Disease (COPD); Age Matched Healthy Volunteers (Non-Smokers)
5
Recruiting
HDAC Inhibitor Vorinostat (SAHA) With Capecitabine (Xeloda) Using a New Weekly Dose Regimen for Advanced Breast Cancer
Last Updated: June 5, 2009
Condition(s): Advanced Breast Cancer
6
Completed
Safety Study of the Histone Deacetylase Inhibitor, CHR-3996, in Patients With Advanced Solid Tumours
Last Updated: November 25, 2011
Condition(s): Solid Tumor
7
Recruiting
The CLARA Study From the Acute Leukemia French Association (ALFA 0702 Trial)
Last Updated: September 29, 2009
Condition(s): Acute Myeloid Leukemia
8
Completed
Study of Vorinostat (MK0683), an HDAC Inhibitor, in Combination With Bortezomib in Patients With Relapsed or Refractory Multiple Myeloma (0683-095 AMJ)
Last Updated: April 17, 2012
Condition(s): Relapsed or Refractory Multiple Myeloma
9
Terminated
ERB-B4 After Treatment With HDAC Inhibitor in ER+ Tamoxifen Refractory Breast Cancer
Last Updated: July 20, 2011
Condition(s): Breast Cancer
10
Recruiting
Oral Histone Deacetylase Inhibitor 4SC-202 in Patients With Advanced Hematologic Malignancies (TOPAS)
Last Updated: February 16, 2012
Condition(s): Advanced Hematologic Malignancies
11
Recruiting
A Study of the Histone Deacetylase Inhibitor (HDACi) JNJ-26481585 in Patients With Previously Treated Stage Ib-IVa Cutaneous T-cell Lymphoma (CTCL)
Last Updated: May 18, 2012
Condition(s): Cutaneous T-cell Lymphoma; Histone Deacetylase Inhibitor; Lymphoma; Oncology
12
Recruiting
Panobinostat in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
Last Updated: April 18, 2012
Condition(s): Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Peripheral T-cell Lymphoma; Post-transplant Lymphoproliferative Disorder; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Small Intestine Lymphoma; Splenic Marginal Zone Lymphoma; Waldenstrom Macroglobulinemia
13
Recruiting
Panobinostat and Everolimus in Treating Patients With Recurrent Multiple Myeloma, Non-Hodgkin Lymphoma, or Hodgkin Lymphoma
Last Updated: May 14, 2012
Condition(s): Hematopoietic/Lymphoid Cancer; Adult Nasal Type Extranodal NK/T-cell Lymphoma; Anaplastic Large Cell Lymphoma; Angioimmunoblastic T-cell Lymphoma; B-cell Adult Acute Lymphoblastic Leukemia; Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue; Hepatosplenic T-cell Lymphoma; Nodal Marginal Zone B-cell Lymphoma; Post-transplant Lymphoproliferative Disorder; Primary Central Nervous System Lymphoma; Recurrent Adult Burkitt Lymphoma; Recurrent Adult Diffuse Large Cell Lymphoma; Recurrent Adult Hodgkin Lymphoma; Recurrent Adult Lymphoblastic Lymphoma; Recurrent Adult T-cell Leukemia/Lymphoma; Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma; Recurrent Grade 1 Follicular Lymphoma; Recurrent Grade 2 Follicular Lymphoma; Recurrent Grade 3 Follicular Lymphoma; Recurrent Mantle Cell Lymphoma; Recurrent Marginal Zone Lymphoma; Recurrent Mycosis Fungoides/Sezary Syndrome; Recurrent Small Lymphocytic Lymphoma; Refractory Multiple Myeloma; Splenic Marginal Zone Lymphoma; T-cell Adult Acute Lymphoblastic Leukemia; Waldenstrom Macroglobulinemia
14
Completed
Phase IIA Study of the HDAC Inhibitor ITF2357 in Patients With JAK-2 V617F Positive Chronic Myeloproliferative Diseases
Last Updated: January 31, 2012
Condition(s): Myeloproliferative Diseases
15
Terminated
phII Study of an HDAC Inhibitor in Very High-risk Relapsed/Refractory Hodgkin's Lymphoma Patients
Last Updated: February 1, 2012
Condition(s): Hodgkin's Lymphoma
16
Terminated
Oral LBH589 in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL)
Last Updated: February 28, 2012
Condition(s): Non-Hodgkin's Lymphoma
17
Terminated
HDAC Inhibitor Valproic Acid as an Effective Therapy for Chronic Lymphocytic Leukemia
Last Updated: July 18, 2011
Condition(s): Chronic Lymphocytic Leukemia
18
Recruiting
Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate
Last Updated: April 19, 2012
Condition(s): Clear Cell Renal Cell Carcinoma; Recurrent Renal Cell Cancer; Stage III Renal Cell Cancer; Stage IV Renal Cell Cancer
19
Terminated
An Investigational Study of a Histone Deacetylase (HDAC) Inhibitor Plus Targretin in Cutaneous T-Cell Lymphoma Patients
Last Updated: April 7, 2010
Condition(s): Lymphoma
20
Active, not recruiting
Study of Vorinostat (MK-0683) an HDAC Inhibitor, or Placebo in Combination With Bortezomib in Patients With Multiple Myeloma (MK-0683-088 AMJ)
Last Updated: October 11, 2011
Condition(s): Multiple Myeloma

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=HDAC

Page 1 of Clinical Trials for HDAC, 373 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About